Cover Image
市場調查報告書

美國的維他命D檢驗市場 (2015∼2019年)

Vitamin D Testing Market in the US 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 347970
出版日期 內容資訊 英文 72 Pages
訂單完成後即時交付
價格
Back to Top
美國的維他命D檢驗市場 (2015∼2019年) Vitamin D Testing Market in the US 2015-2019
出版日期: 2015年12月23日 內容資訊: 英文 72 Pages
簡介

一般認為美國國內的維他命D檢驗市場,今後將穩定成長。該市場到2019年的年複合成長率(CAGR) 估計約4%。各種急性、慢性疾病的預防,成為主要市場成長要素。維他命D的缺乏症,有可能引起佝僂病和骨質疏鬆症等慢性疾病,及幼兒期的心血管疾病、癌症、氣喘發病,認知障礙,自體免疫等。反過來說,由於頻繁檢查維他命D水準,可預防這些疾病,更加掌握整體醫療費負擔。主要的檢驗項目,有25-羥維生素D檢驗和1, 25-羥基維生素D2種,而25-羥基維生素D檢驗佔整體約76%。

本報告提供美國的維他命D檢驗的市場相關分析、檢驗手法概要和市場基本結構、市場規模趨勢 (今後5年的預測值)、各用途詳細趨勢、推動&阻礙市場要素與其影響力、主要企業簡介、今後的市場機會等調查評估。

第1章 摘要整理

  • 分析結果的概要

第2章 分析範圍

  • 分析概要
  • 大供應商的主要產品

第3章 市場分析技術

  • 分析方法
  • 經濟指標

第4章 簡介

  • 市場趨勢的概要

第5章 美國的維他命D檢驗市場現狀

  • 維他命D檢驗技術
  • 美國的維他命D檢驗的標準化計劃

第6章 美國的維他命D檢驗的市場規模預測 (以數量為準,今後5年份)

  • 市場規模與其預測

第7章 市場環境

  • 市場概要
  • 市場規模與其預測
  • 波特的五力分析

第8章 各用途的市場區隔

  • 25-羥維生素D檢驗
  • 1, 25-羥基維生素D檢驗

第9章 推動市場要素

第10章 推動因素的影響力

第11章 市場課題

第12章 推動因素、課題的影響力

第13章 市場趨勢

第14章 供應商環境

  • 競爭方案
  • 主要供應商分析
  • 其他卓越供應商

第15章 主要供應商分析

  • Abbott Diagnostics
  • bioMerieux
  • DiaSorin
  • Quest Diagnostics
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics

第16章 附錄

  • 簡稱集

第17章 關於Technavio

圖表一覽

目錄
Product Code: IRTNTR7745

Market outlook of the vitamin D testing market in the US

Technavio's market research analyst has estimated this market to show steady growth during the forecast period. The prospect for growth in this market is dependent on factors like the high incidence of vitamin D deficiency among the populace in this region, which results in its slow but moderate CAGR of around 4% by 2019.

The prevention of various acute and chronic diseases is the key driver for the growth of this market. Vitamin D deficiency can lead to various chronic diseases like rickets and osteoporosis, and can also result in cardiovascular diseases, cancer, asthma in infants, cognitive disorders, and autoimmune diseases. The incidence of these diseases can be reduced by frequently testing the vitamin D levels, which in turn would help to reduce the overall healthcare expenditure.

Application-based segmentation and analysis of - 25-Hydroxy vitamin D tests & 1,25-Dihydroxy vitamin D test

In this market research report, analysts estimate the 25-Hydroxy vitamin D tests segment to be the largest market segment during the forecast period. Currently, this market segment accounts for a share of nearly 76% and is envisaged to retain its dominating hold over the market by 2019. The ability of 25-Hydroxy vitamin D tests to identify bone malformations and softness, bone weakness, or fractures in adults is one of the most significant factors that accounts for its high market share during the forecast period.

The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -

  • 25-Hydroxy vitamin D tests
  • 1,25-Dihydroxy vitamin D test

Competitive landscape and key vendors - Roche Diagnostics, Abbott Diagnostics

This market is highly competitive and consists of vendors that focus on test development and research. These vendors compete on the basis of price, quality, and breadth of product line, technology, and distribution capabilities to gain maximum prominence in the market.

Key vendors in this market are -

  • Roche Diagnostics
  • Abbott Diagnostics
  • Siemens Healthcare Diagnostics
  • Biomeriux
  • Diasorin
  • Quest Diagnostics

Other prominent vendors analyzed in this market research are Diazyme laboratories, Biokit, ESA Biosciences, Quest Diagnostics Inc., The Vitamin D Company, Tosoh Bioscience Inc., Qualigen Inc., Dade Behring, DIAsource ImmunoAssays S.A, Ortho-Clinical Diagnostics, Piramal Healthcare, Beckman Coulter, and Becton Dickinson.

Growth drivers, challenges, and upcoming drivers - Vitamin D

Upcoming trends such as the augmented adoption of home vitamin D testing kits are rapidly gaining popularity as they are highly cost efficient. Since this market is facing declining reimbursement, patients have to pay out of their pockets to perform these tests. Therefore, in recent times, it has been observed that many patients prefer carrying out such tests at the convenience of their homes as it reduces the overall expenditure.

This report provides a number of factors contributing to the adoption, limitations, and opportunities of the vitamin D testing market in the US. It also offers an analysis of each factor and an estimation of the extent to which the factors are likely to impact the overall market growth.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2019?
  • What are the key factors driving the vitamin D testing market in the US?
  • What are the key market trends impacting the growth of the vitamin D testing market in the US?
  • What are the challenges to market growth?
  • Who are the key vendors in the vitamin D testing market in the US?
  • What are the market opportunities and threats faced by the vendors in the vitamin D testing market in the US?
  • Trending factors influencing the market shares of the US?
  • What are the key outcomes of the five forces analysis of the vitamin D testing market in the US?

Technavio also offers customization on reports based on specific client requirement.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Vitamin D status in US

  • Methods for vitamin D testing
  • Standardization program for vitamin D test in US

PART 06: Vitamin D testing market by volume in US 2015-2019

  • Market size and forecast

PART 07: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 08: Market segmentation by application

  • 25-hydroxy vitamin D test
  • 1, 25-dihydroxy vitamin D test

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape

  • Competitive scenario
  • Key prominent vendors
  • Other prominent vendors

PART 15: Key vendor analysis

  • Abbott Diagnostics
  • bioMerieux
  • DiaSorin
  • Quest Diagnostics
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Vitamin D sources
  • Exhibit 03: FDA approved products for vitamin D testing in US
  • Exhibit 04: Market opportunity for vitamin D testing in chronic kidney diseases
  • Exhibit 05: Phases of standardization program
  • Exhibit 06: Total volume of vitamin D tests performed in US 2015-2019 (millions)
  • Exhibit 07: Segmentation of vitamin D testing market in US
  • Exhibit 08: Vitamin D testing market in US 2015-2019 by sales revenue ($ millions)
  • Exhibit 09: Five forces analysis
  • Exhibit 10: Vitamin D testing market in US based on application
  • Exhibit 11: Vitamin D testing market by application in 2014
  • Exhibit 12: Impact of drivers
  • Exhibit 13: Impact of drivers and challenges
  • Exhibit 14: Abbott Diagnostics: Key takeaways
  • Exhibit 15: bioMerieux: Key takeaways
  • Exhibit 16: DiaSorin: Key takeaways
  • Exhibit 17: Quest Diagnostics: Key takeaways
  • Exhibit 18: Roche Diagnostics: Key takeaways
  • Exhibit 19: Siemens Healthcare Diagnostics: Key takeaways
  • Exhibit 20: Abbott Diagnostics: Key business offerings
  • Exhibit 21: bioMerieux: Applications by technology
  • Exhibit 22: DiaSorin: Business segmentation by revenue 2013 and 2014
  • Exhibit 23: DiaSorin: Geographical segmentation by revenue 2014
  • Exhibit 24: Quest Diagnostics: Business segmentation
  • Exhibit 25: Quest Diagnostics: Business segmentation by revenue 2014
  • Exhibit 26: Quest Diagnostics: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 27: Roche Diagnostics: Business segmentation by revenue 2014
  • Exhibit 28: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 29: Roche Diagnostics: Geographical segmentation by revenue 2014
  • Exhibit 30: Siemens Healthcare Diagnostics: Business segmentation
  • Exhibit 31: Siemens Healthcare Diagnostics: Geographical segmentation by revenue 2014
Back to Top